Developing a Metagenomic View of Xenobiotic Metabolism

Overview

Journal Pharmacol Res

Publisher Elsevier

Specialty Pharmacology

Date 2012 Aug 21

PMID 22902524

Citations 74

Authors

Henry J Haiser

Peter J Turnbaugh

Affiliations

Soon will be listed here.

Abstract

The microbes residing in and on the human body influence human physiology in many ways, particularly through their impact on the metabolism of xenobiotic compounds, including therapeutic drugs, antibiotics, and diet-derived bioactive compounds. Despite the importance of these interactions and the many possibilities for intervention, microbial xenobiotic metabolism remains a largely underexplored component of pharmacology. Here, we discuss the emerging evidence for both direct and indirect effects of the human gut microbiota on xenobiotic metabolism, and the initial links that have been made between specific compounds, diverse members of this complex community, and the microbial genes responsible. Furthermore, we highlight the many parallels to the now well-established field of environmental bioremediation, and the vast potential to leverage emerging metagenomic tools to shed new light on these important microbial biotransformations.

Citing Articles

Effects of glyphosate, antibiotics, and an anticoccidial drug on pancreatic gene expression and blood physiology in broilers.

Laptev G, Tiurina D, Yildirim E, Gorfunkel E, Ilina L, Filippova V J Zhejiang Univ Sci B. 2025; 26(2):185-199.

PMID: 40015937 PMC: 11867781. DOI: 10.1631/jzus.B2300767.

Biosynthetic enzyme analysis identifies a protective role for TLR4-acting gut microbial sulfonolipids in inflammatory bowel disease.

Older E, Zhang J, Ferris Z, Xue D, Zhong Z, Mitchell M Nat Commun. 2024; 15(1):9371.

PMID: 39477928 PMC: 11525784. DOI: 10.1038/s41467-024-53670-y.

Microbiome and pancreatic cancer: time to think about chemotherapy.

De Castilhos J, Tillmanns K, Blessing J, Larano A, Borisov V, Stein-Thoeringer C Gut Microbes. 2024; 16(1):2374596.

PMID: 39024520 PMC: 11259062. DOI: 10.1080/19490976.2024.2374596.

Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome.

De Filippis F, Valentino V, Sequino G, Borriello G, Riccardi M, Pierri B Nat Commun. 2024; 15(1):4482.

PMID: 38802370 PMC: 11130323. DOI: 10.1038/s41467-024-48739-7.

The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients.

Belei O, Basaca D, Olariu L, Pantea M, Bozgan D, Nanu A J Clin Med. 2024; 13(5).

PMID: 38592680 PMC: 10932475. DOI: 10.3390/jcm13051361.

References

McBain A, Macfarlane G . Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol. 1999; 47(5):407-16. DOI: 10.1099/00222615-47-5-407. View

Reichardt N, Barclay A, Weaver L, Morrison D . Use of stable isotopes to measure the metabolic activity of the human intestinal microbiota. Appl Environ Microbiol. 2011; 77(22):8009-14. PMC: 3208973. DOI: 10.1128/AEM.05573-11. View

Tobin P, Dodds H, Clarke S, Schnitzler M, Rivory L . The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. Oncol Rep. 2003; 10(6):1977-9. View

Elmer G, Remmel R . Role of the intestinal microflora in clonazepam metabolism in the rat. Xenobiotica. 1984; 14(11):829-40. DOI: 10.3109/00498258409151481. View

Nakayama H, Kinouchi T, Kataoka K, Akimoto S, Matsuda Y, Ohnishi Y . Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil. Pharmacogenetics. 1997; 7(1):35-43. DOI: 10.1097/00008571-199702000-00005. View

Chan R, Pope D, Gilbert A, SACRA P, Baron J, Lennard-Jones J . Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci. 1983; 28(7):609-15. DOI: 10.1007/BF01299921. View

Smillie C, Smith M, Friedman J, Cordero O, David L, Alm E . Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011; 480(7376):241-4. DOI: 10.1038/nature10571. View

Manach C, Scalbert A, Morand C, Remesy C, Jimenez L . Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79(5):727-47. DOI: 10.1093/ajcn/79.5.727. View

Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit A . The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008; 363(1-2):1-25. DOI: 10.1016/j.ijpharm.2008.07.009. View

10.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

11.

Radajewski S, Ineson P, Parekh N, Murrell J . Stable-isotope probing as a tool in microbial ecology. Nature. 2000; 403(6770):646-9. DOI: 10.1038/35001054. View

12.

Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E . Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000; 36(1):27-32. DOI: 10.1207/S15327914NC3601_5. View

13.

Gans J, Wolinsky M, Dunbar J . Computational improvements reveal great bacterial diversity and high metal toxicity in soil. Science. 2005; 309(5739):1387-90. DOI: 10.1126/science.1112665. View

14.

Faith J, Rey F, ODonnell D, Karlsson M, McNulty N, Kallstrom G . Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 2010; 4(9):1094-8. PMC: 2927777. DOI: 10.1038/ismej.2010.110. View

15.

Goldin B, Peppercorn M, Goldman P . Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. J Pharmacol Exp Ther. 1973; 186(1):160-6. View

16.

Goldman P . Biochemical pharmacology of the intestinal flora. Annu Rev Pharmacol Toxicol. 1978; 18:523-39. DOI: 10.1146/annurev.pa.18.040178.002515. View

17.

Watanabe K, Yamashita S, Furuno K, Kawasaki H, Gomita Y . Metabolism of omeprazole by gut flora in rats. J Pharm Sci. 1995; 84(4):516-7. DOI: 10.1002/jps.2600840425. View

18.

van Nuenen M, Venema K, van der Woude J, Kuipers E . The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004; 49(3):485-91. DOI: 10.1023/b:ddas.0000020508.64440.73. View

19.

Sasaki I, Tamura T, Shibakawa T, Fujita T, Murakami M, Yamamoto A . Metabolism of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, by intestinal microorganisms. Pharm Res. 1997; 14(8):1004-7. DOI: 10.1023/a:1012141025938. View

20.

Caldwell J, Hawksworth G . The demethylation of methamphetamine by intestinal microflora. J Pharm Pharmacol. 1973; 25(5):422-4. DOI: 10.1111/j.2042-7158.1973.tb10043.x. View